INVESTORS
NEWS
• 2009
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003
EVENTS
CAREERS
• Job Opportunities
CONTACT
ABOUT US
• Mission
• Management
• Board of Directors
• Clinical Advisory Boards
• Scientific Advisory Boards
PIPELINE
HIV
• Vacc-4x
• Vacc-5q
• Vacc-C5
Other indications
• Influenza
• HCV
• Cervical Cancer (HPV)
RESEARCH
• Area of focus
• Peptide Design
• Peptide Delivery
SITEMAP
home
about us
pipeline
investors
research
news
events
careers
sitemap
contact
© 2008 BionorImmuno, Inc. All rights Reserved
ABOUT US
PIPELINE
RESEARCH
NEWS
SITEMAP
CONTACT US
EVENTS
CAREERS
HOME
INVESTORS
Bionor Immuno AS, a subsidary of Bionor Pharma ASA was established on July 14th 2000 as a spin off from the R&D on immune based therapies that until then had been performed by its sister company, Bionor AS. Both companies are located at the Telemark Biomedical Centre, Skien, Norway together with two of its development partners AS Telelab and Mericon AS.